[
  {
    "ts": null,
    "headline": "FDA classifies recall of Boston Scientific catheters as 'most serious'",
    "summary": "The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's catheters used in a type of minimally invasive surgery as most serious. The recall involves...",
    "url": "https://finnhub.io/api/news?id=0cfa9b297833fce121007f09cdd000b3626d1c73ffedda03bfa21d7661011e0f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734540091,
      "headline": "FDA classifies recall of Boston Scientific catheters as 'most serious'",
      "id": 132041754,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's catheters used in a type of minimally invasive surgery as most serious. The recall involves...",
      "url": "https://finnhub.io/api/news?id=0cfa9b297833fce121007f09cdd000b3626d1c73ffedda03bfa21d7661011e0f"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock underperforms Wednesday when compared to competitors",
    "summary": "Boston Scientific Corp. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=0c9437fbd3278b35c5826428603cd540e656e6fdcab31092fd31d9c54f967bd4",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734540000,
      "headline": "Boston Scientific Corp. stock underperforms Wednesday when compared to competitors",
      "id": 132067212,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=0c9437fbd3278b35c5826428603cd540e656e6fdcab31092fd31d9c54f967bd4"
    }
  },
  {
    "ts": null,
    "headline": "BSX Trades Near 52-Week High: Does the Stock Hold More Potential?",
    "summary": "We believe Boston Scientific is one of those MedTech manufacturers that can be considered as the biggest gainers from the Fed's two successive interest rate cuts in 2024.",
    "url": "https://finnhub.io/api/news?id=91124e5a05b46e9f7ca919d9d312277b0a165c9d1229b90a85b776ed08982d8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734537120,
      "headline": "BSX Trades Near 52-Week High: Does the Stock Hold More Potential?",
      "id": 132048311,
      "image": "https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "We believe Boston Scientific is one of those MedTech manufacturers that can be considered as the biggest gainers from the Fed's two successive interest rate cuts in 2024.",
      "url": "https://finnhub.io/api/news?id=91124e5a05b46e9f7ca919d9d312277b0a165c9d1229b90a85b776ed08982d8e"
    }
  },
  {
    "ts": null,
    "headline": "The Gabelli Growth Fund Q3 2024 Commentary",
    "summary": "The Gabelli Growth Fund (class I) returned 0.87% for the third quarter of 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=59814581654cd262c800ea15833ef67564affcf70af4fff652d3a9a44136f5aa",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734519000,
      "headline": "The Gabelli Growth Fund Q3 2024 Commentary",
      "id": 132039550,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1400960132/image_1400960132.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "The Gabelli Growth Fund (class I) returned 0.87% for the third quarter of 2024. Click here to read the full commentary. \n",
      "url": "https://finnhub.io/api/news?id=59814581654cd262c800ea15833ef67564affcf70af4fff652d3a9a44136f5aa"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Global Impact Fund Q3 2024 Commentary",
    "summary": "The Hartford Global Impact Fund (I share) outperformed the MSCI ACWI Index during the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=8d26cae021bd722f4957d5444ea9a1396f7a28ea09b4f00d742dc012b1338593",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734501060,
      "headline": "Hartford Global Impact Fund Q3 2024 Commentary",
      "id": 132037681,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1484736771/image_1484736771.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "The Hartford Global Impact Fund (I share) outperformed the MSCI ACWI Index during the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=8d26cae021bd722f4957d5444ea9a1396f7a28ea09b4f00d742dc012b1338593"
    }
  }
]